en
Feedback
Boards and Beyond 2026

Boards and Beyond 2026

Open in Telegram

📈 Analytical overview of Telegram channel Boards and Beyond 2026

Channel Boards and Beyond 2026 (@boards_beyond) is an active participant. Currently, the community unites 46 255 subscribers, ranking 363 in the Medicine category and 8 149 in the India region.

📊 Audience metrics and dynamics

Since its creation on невідомо, the project has demonstrated rapid growth, gathering an audience of 46 255 subscribers.

According to the latest data from 31 July, 2026, the channel demonstrates stable activity. Although there has been a change in the number of participants by 209 over the last 30 days and by 0 over the last 24 hours, overall reach remains high.

  • Verification status: Not verified
  • Engagement rate (ER): The average audience engagement rate is 0%. Within the first 24 hours after publication, content typically collects N/A% reactions from the total number of subscribers.
  • Post reach: On average, each post receives 0 views. Within the first day, a publication typically gains 0 views.
  • Reactions and interaction: The audience actively supports content: the average number of reactions per post is 0.

📝 Description and content policy

Channel description not provided.

Thanks to the high frequency of updates (latest data received on 01 August, 2026), the channel maintains relevance and a high level of publication reach. Analytics show that the audience actively interacts with content, making it an important point of influence in the Medicine category.

46 255
Subscribers
No data24 hours
+367 days
+20930 days
Posts Archive
🩺 #Step2 256 Videos #C1: Behavioral Science #C2: Cardiology #C3: Emergency Medicine #C4 : Endocrinology #C5: Epidemiology #C6: Gastroenterology #C7: Red Cells and Coagulation #C8: Infectious Disease #C9: Neurology #C10: Obstetrics and Gynecology #C11: Pediatrics #C12: Psychiatry #C13: Pulmonary Critical Care #C14: Renal & Genitourinary

🩺 #Step1 477 videos #B1: Basic Pharmacology #B2: Behavioral Science #B3: Biochemistry #B4: Biostatistics and Epidemiology #B5: Cardiology #B6: Cell Biology #B7: Dermatology #B8: Endocrinology #B9: Gastroenterology #B10: Genetics #B11: Hematology #B12: Immunology #B13: Infectious Disease #B14: Musculoskeletal #B15: Anesthesia #B16: Pathology #B17: Psychiatry #B18: Renal #B19: Reproductive

256 - Surgery - Pre-operative Evaluation @Vid4Med

255 - Surgery - Post-Operative Complications @Vid4Med

254 - Anesthesia - Regional and Local Anesthesia @Vid4Med

253 - Anesthesia - Neuromuscular Blockers @Vid4Med

252 - Anesthesia - Intravenous Anesthetics @Vid4Med

251 - Anesthesia - General Anesthesia @Vid4Med

250 - Renal Failure - Chronic Kidney Disease @Vid4Med

249 - Renal Failure - Acute Renal Failure @Vid4Med

248 - Other Topics - Urinary Tract Malignancy @Vid4Med

247 - Other Topics - Urinary Infections @Vid4Med

246 - Other Topics - Urinary Incontinence @Vid4Med

245 - Other Topics - Tubulointerstitial Disorders @Vid4Med

244 - Other Topics - Rhabdomyolysis @Vid4Med

243 - Other Topics - Nephrolithiasis @Vid4Med

242 - Other Topics - Hematuria @Vid4Med

241 - Other Topics - Diuretics @Vid4Med

240 - Other Topics - Cystic Kidney Disease @Vid4Med

239 - Glomerular Disease - RPGN @Vid4Med